Secure the commercial success of your cell therapy product with our perfect match
Seamless workflow integration and automation are essential for efficient cell therapy product development and commercial success. Major challenges often arise from a lack of expertise, product variability, unreliable analytics, patchwork workflows, and meeting stringent regulatory requirements.
Simultaneous optimization of manufacturing and analytical procedures to reduce complexity and improve scalability is key to market success.
With over three decades of hands-on experience in cell and gene therapy (CGT), we support you with a sophisticated platform solution for your cell therapy endeavors. The perfect match of CliniMACS Prodigy® and MACSQuant® Analyzer 16 provides you with a customizable workflow that streamlines your manufacturing and analysis.
Explore the platform solution: manufacturing and analytics go together
Dedicated to streamlining your cell manufacturing and analytics
CliniMACS Prodigy Platform: integrated cell processing and manufacturing
Highly automated, yet fully customizable, our all-in-one solution for cell processing and manufacturing provides everything you need.
- Integrated platform: one versatile platform from cell labeling to cell product filling
- Fully automated platform: reduced manual process steps for improved reproducibility
- From product development to commercialization: easy product development and transition to commercial scale
- Outstanding processing platform: proven 150+ clinical trials and commercial manufacturing
Learn more about the CliniMACS Prodigy Platform
MACSQuant Analyzer 16: automated flow cytometry for robust analytics
This flexible platform is designed for use in GMP-compliant cell manufacturing environments, with bespoke analytical features to provide precision and maximum flexibility.
- Audit-ready software: 21 CFR Part 11 module, automated gating and analysis, multi-instrument alignment
- Automated platform: automated sample mixing, processing, autolabeling
- True volumetric cell counting: without counting beads
- In-line enrichment of rare cells: with integrated MACS® Magnetic Cell Enrichment
Learn more about the MACSQuant Analyzer 16
Streamline your cell therapy development and secure commercial success
We offer state-of-the-art manufacturing procedures integrated with harmonized analytics for seamless in-process and release testing (IPC/RT), tailored to meet the demands of your individual CGT strategies.
Whether your focus is on gene-modified cells, immuno-oncology, regenerative medicine, or graft-engineered cells, our comprehensive offerings are designed to support a wide range of cell manufacturing procedures. In addition, we can provide you with customized solutions for both manufacturing and analytics to significantly shorten your development timeline.
Looking for an industry-wide established workflow? We are here to deliver tailored solutions for every stage of your project, regardless of its complexity or your level of experience.
With us, you will benefit from:
- Seamless integration of manufacturing procedures and analytics
- Fully customizable solutions
- A scalable platform for every step of the development process